There remains an
unmet need for innovative treatments for chronic
wound infections as they continue to be a financial and social burden
on society. Because of the dynamic nature of wounds, this study investigated
the utilization of stimulus-responsive plasma polymers for the development
of pH- and thermoresponsive antibiotic delivery systems for the treatment
of wound infections. Porous silicon films were loaded with the antibiotic
levofloxacin (LVX) and subsequently coated with plasma polymer layers:
first, poly(1,7-octadiene) (pOCT) for stability, followed by either
the temperature-responsive polymer poly N,N-diethylacrylamide (pDEA)
or the pH- responsive polymer poly 2-(diethylamino)ethyl methacrylate
(pDEAEMA), to fabricate two delivery systems. The delivery systems
were thoroughly characterized chemically and physically and tested
in vitro through drug release and bacterial zone of inhibition studies.
After a 16 h time point, the system containing pDEA achieved 3.2-fold
greater release at 45 °C compared to 22 °C, whereas the
system containing pDEAEMA achieved a 2.2-fold greater release when
exposed to pH 8.5 media compared to pH 6.2 media. Furthermore, both
systems retained their antimicrobial activity and demonstrated stimulus-responsive
release to form zones of inhibition on relevant wound pathogens, Pseudomonas aeruginosa, Staphylococcus epidermidis and Staphylococcus aureus. Therefore, this proof-of-principle
study confirms that stimulus-responsive porous silicon films can be
utilized to deliver antibiotic when exposed to physiologically relevant
stimuli such as pH and temperature with the potential to be applied
to other pharmaceutics.